Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISSCollaboration Aims to Enhance Healthspan on Earth and Improve Astronaut Health in SpaceIM8, a new premium supplements brand launched officially on November 18th on IM8health.com CHARLOTTE, N.C., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Prenetics’ IM8 is excited to announce that its groundbreaking month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now unde ...

Core Insights - Prenetics Global Limited, a leading health sciences company, will participate in two upcoming investor conferences in December 2024 [1][2][3] Group 1: Upcoming Conferences - The iAccess Alpha Virtual Best Ideas Winter Conference 2024 will take place on December 10-11, 2024, with a presentation by CEO Danny Yeung on December 10 at 10:00am ET [2] - One-on-one investor meetings will be held on December 11, 2024, featuring CEO Danny Yeung, CFO Stephen Lo, and President of Prenetics Americas David Vanderveen [2] - The 13th Annual ROTH Deer Valley Event will occur from December 11-13, 2024, in Park City, UT, where David Vanderveen will host one-on-one investor meetings [3] Group 2: Company Overview - Prenetics is dedicated to advancing consumer and clinical health, with initiatives including the IM8 health and wellness brand and Europa, a major sports distribution company in the USA [5] - The clinical division includes Insighta, a $200 million venture focused on multi-cancer early detection technologies, and ACT Genomics, which has received FDA clearance for comprehensive genomic profiling of solid tumors [5] - CircleDNA offers comprehensive DNA tests using next-generation sequencing (NGS), enhancing Prenetics' global impact on health [5]

Core Insights - RocketFuel Blockchain, Inc. anticipates revenue of $2,250,000 for the first three quarters of 2024, more than double the revenue from the same period last year [2] - The company processed a total of 1 million payment transactions with zero downtime over the last four quarters [2] - RocketFuel has served approximately 400,000 unique users/shoppers [3] Company Overview - RocketFuel is a leading provider of payment processing solutions, focusing on innovative and secure services for businesses of all sizes [4] - The company emphasizes exceptional customer experiences and revenue growth, utilizing enterprise-class infrastructure and cutting-edge technology [4] - RocketFuel has demonstrated robust growth since its inception and continues to expand its customer base with industry-leading solutions [4]

Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta’s Early Cancer Detection Reiterates Revenue Target to Exceed $33 million for FY 2024 CHARLOTTE, N.C., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the third quarter ended September 30, 202 ...

Group 1 - Prenetics will participate in the Sidoti Virtual Micro Cap Conference on November 13-14, 2024 [1] - CEO Danny Yeung and CFO Stephen Lo will present virtually on November 13th at 8:30 a.m. ET [2] - Management will be available for one-on-one investor meetings on November 13th [3] Group 2 - Prenetics is a leading health sciences company focused on advancing consumer and clinical health [4] - The company’s consumer initiative includes IM8 and Europa, while its clinical division features Insighta, a $200 million venture for multi-cancer early detection technologies [4] - ACT Genomics has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA offers comprehensive DNA tests using NGS [4]

Core Insights - David Beckham has become a strategic investor in Prenetics, co-founding a new health and wellness brand named IM8, which will focus on innovative consumer health products [2] - Beckham's involvement is seen as a transformative opportunity for Prenetics in global health innovation and wellness, aligning with the company's core principles [2] Company Overview - Prenetics (NASDAQ:PRE) is a leading health sciences company dedicated to advancing consumer and clinical health, with a consumer initiative led by the new brand IM8 [5] - The clinical division of Prenetics includes Insighta, a $200 million joint venture focused on multi-cancer early detection technologies, and ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors [5] Strategic Partnership - Beckham's partnership with Prenetics is expected to enhance the company's mission of making health accessible to all, reflecting his values of discipline, teamwork, and health [2] - The collaboration aims to leverage Beckham's vision and passion for health to contribute meaningfully to the consumer health and wellness industry [2] Innovations and Impact - Prenetics is recognized for its significant innovations, including non-invasive prenatal testing discovered by Professor Dennis Lo, which is used by over 15 million expectant mothers annually in 90 countries [9] - The company is also focused on early cancer detection technologies, which have the potential to improve survival rates through earlier intervention [9]

LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company, welcomes Kathryn M. Henry and David Vanderveen as independent directors to the Company's Board of Directors. "We are excited to welcome Kathryn and David to Prenetics' Board of Directors at this pivotal juncture," said Danny Yeung, CEO of Prenetics. "Their unparalleled expertise in consumer and health sectors, combined with their proven leadership in driving ...

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range of US$33 million to US$36 million LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the first quarter ended March 31, 2024, along with recent business updates. Firs ...

LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, has engaged international investor relations specialists MZ Group ("MZ") to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Prenetics management to develop and implement a capital markets strategy designed to increase the Company's visibility throug ...

ATLANTA, June 5, 2024 /PRNewswire/ -- DYMO®, a leading provider of innovative labeling solutions and part of the Newell Brands global portfolio, and Taylor, a renowned name in custom label manufacturing, have announced a strategic partnership that makes custom-printed LabelWriter® labels available for use with DYMO LabelWriter® 5 Series printers.(L) Joe Klenke, President, Taylor Labeling Solutions (M) Kris Malkoski, Segment CEO, Learning & Development, Newell Brands (R) Steve Mcdonell, Vice President of Eng ...